Skip to main content

New “Legal Highs” On The Rise

Amateur chemists are creating new recreational drugs at such a rate that governments cannot keep up.
 

Written byDan Cossins
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00

Half a gram of JWH-018, a synthetic cannabinoidWIKIMEDIA, PSYCHONAUGHTThe creation, supply, and use of new synthetic drugs is on the rise across the Western world and governments are struggling to keep track and regulate the variety of substances, according to a report from the United Nations Office on Drugs and Crime (UNODC).

Some of these “designer drugs” have hit the headlines but there are hundreds more on the market, and amateur chemists in professional-standard home laboratories are developing new substances all the time. Indeed, the European Monitoring Center from Drugs and Addiction reported 73 new drugs in 2012—with new substances arriving on the market at a rate of more than one a week.

In Britain, the UNODC report said, almost 700,000 people aged between 15 and 24 have experimented with these “legal highs,” though the report adds that the biggest market is the United States, where use of the substances “appears to be more than twice as widespread as in the European Union.”

Sold openly on the Internet under euphemistic descriptions such as “bath salts,” “incense,” and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays